Once-Weekly Ofatumumab in Untreated or Relapsed Waldenström's Macroglobulinaemia: An Open-Label, Single-Arm, Phase 2 Study
The Lancet Haematology - United Kingdom
doi 10.1016/s2352-3026(16)30166-1
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2017
Authors
Publisher
Elsevier BV